Skip to main content

Is Controversy Over NCRT Plus Surgery Warranted in Esophageal Squamous Cell Carcinoma?

Neoadjuvant chemoradiotherapy (NCRT) plus surgery significantly improves survival vs surgery alone in locally advanced esophageal squamous cell carcinoma (ESCC), with acceptable and manageable adverse events, according to a new study.
http://www.cancernetwork.com/head-neck-cancer/controversy-over-ncrt-plus-surgery-warranted-esophageal-squamous-cell-carcinoma

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino